Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
KenChowder's Profile
Displaying 51-100 of 1190 result(s).
CYDY CytoDyn Inc
06/02/2025 2:20:56 AM
Not sure what this one has to do wi (1)
CYDY CytoDyn Inc
06/02/2025 2:14:49 AM
So the abstract appeared in Februar (1)
CYDY CytoDyn Inc
06/01/2025 3:18:35 PM
Article from February 2025, I belie (4)
CYDY CytoDyn Inc
05/31/2025 6:43:24 AM
Debu Tripathy is the new Scientific (25)
CYDY CytoDyn Inc
05/30/2025 11:21:53 AM
The DSMB can then recommend restric (3)
CYDY CytoDyn Inc
05/30/2025 3:23:59 AM
Usually around halfway through a tr (9)
CYDY CytoDyn Inc
05/28/2025 1:25:06 PM
Article in Benzinga re CYDY, "A Pen (11)
CYDY CytoDyn Inc
05/27/2025 11:58:06 AM
Agree. I've wondered if you could i (8)
CYDY CytoDyn Inc
05/27/2025 10:06:36 AM
Hey, that's a great question! Yes, (5)
CYDY CytoDyn Inc
05/27/2025 7:03:10 AM
No, it's hasn't been trialed on hum (5)
CYDY CytoDyn Inc
05/27/2025 2:35:45 AM
Is Leronlimab ready for human trial (12)
CYDY CytoDyn Inc
05/24/2025 12:09:39 PM
It absolutely is a stunning result. (11)
CYDY CytoDyn Inc
05/23/2025 10:27:22 AM
We discussed this when the Barca co (3)
CYDY CytoDyn Inc
05/22/2025 3:06:05 PM
Not sure what the date was of my fi (22)
CYDY CytoDyn Inc
05/22/2025 9:26:06 AM
That AI response doesn't mention PD (2)
CYDY CytoDyn Inc
05/22/2025 3:13:29 AM
I believe an option for an ICI will (18)
CYDY CytoDyn Inc
05/21/2025 4:56:38 PM
Pfizer once paid a multiple of 3.13 (2)
CYDY CytoDyn Inc
05/21/2025 3:38:24 PM
Hi. I've posted something like this (27)
CYDY CytoDyn Inc
05/20/2025 5:01:04 PM
An article titled The Role and Ther (5)
CYDY CytoDyn Inc
05/20/2025 7:10:21 AM
There might be a double opportunity (9)
CYDY CytoDyn Inc
05/19/2025 12:19:46 PM
Nice find by My69z. Here's the link (3)
CYDY CytoDyn Inc
05/18/2025 7:11:00 PM
Sjacobs knows what CRC stands for.
CYDY CytoDyn Inc
05/18/2025 10:52:38 AM
That's the trouble with AI, which I (7)
CYDY CytoDyn Inc
05/18/2025 5:14:46 AM
Nice post, S. Re the FDA recognizin (12)
CYDY CytoDyn Inc
05/17/2025 5:38:34 PM
I was either quoting or misquoting (3)
CYDY CytoDyn Inc
05/17/2025 5:14:39 PM
Thanks, Kat. I don't know if an ICI (4)
CYDY CytoDyn Inc
05/17/2025 4:12:54 PM
Note from Max Lataillade on LinkedI (39)
CYDY CytoDyn Inc
05/16/2025 3:49:52 PM
I'm not saying Keytruda wouldn't be (3)
CYDY CytoDyn Inc
05/16/2025 2:05:05 PM
Thanks for the Monty Python referen (1)
CYDY CytoDyn Inc
05/16/2025 9:43:41 AM
It is true that approvals are for t (12)
CYDY CytoDyn Inc
05/15/2025 4:25:50 PM
Of all the flags pointing in the r (16)
CYDY CytoDyn Inc
05/15/2025 12:41:43 PM
An MSN headlineL CytoDyn's new data (16)
CYDY CytoDyn Inc
05/15/2025 9:58:34 AM
What we know about that 7th patient (7)
CYDY CytoDyn Inc
05/15/2025 9:03:48 AM
The number in Figure 5 of those tre (19)
CYDY CytoDyn Inc
05/14/2025 5:10:26 PM
As the PR said, 5/5 patients (100%) (21)
CYDY CytoDyn Inc
05/13/2025 4:07:10 PM
On my post after this one I correct (10)
CYDY CytoDyn Inc
05/13/2025 9:41:33 AM
We don't just improve the SOC. In 8 (9)
CYDY CytoDyn Inc
05/13/2025 9:31:13 AM
Forgot to add this: "CytoDyn’s re (26)
CYDY CytoDyn Inc
05/13/2025 9:23:29 AM
My takeaway from the PR is this, an (26)
CYDY CytoDyn Inc
05/09/2025 10:19:27 AM
Mr. 3 has a guess about next PR. I' (9)
CYDY CytoDyn Inc
05/08/2025 9:34:06 AM
Midnight, I don't think Tecentric b (8)
CYDY CytoDyn Inc
05/08/2025 2:56:53 AM
Only 3 of the 28 patients had the o (4)
CYDY CytoDyn Inc
05/08/2025 2:35:43 AM
So we were very close. We only mana (12)
CYDY CytoDyn Inc
05/07/2025 6:17:01 PM
So the statistical takeaway as I se (14)
CYDY CytoDyn Inc
05/07/2025 6:06:53 PM
Here's the abstract from the Munich (8)
CYDY CytoDyn Inc
05/07/2025 10:06:04 AM
Look at the Bid and Ask this mornin (6)
CYDY CytoDyn Inc
05/06/2025 10:45:42 AM
And that same month.... Budget and (6)
CYDY CytoDyn Inc
05/06/2025 9:18:08 AM
If a billion bucks gets taken away (6)
CYDY CytoDyn Inc
05/06/2025 8:58:33 AM
Misiu write: "What has the Gov to d (8)
CYDY CytoDyn Inc
05/06/2025 3:13:46 AM
Great post, MGK. Not a single milit (7)
Go to page:
  • << First
  • < Previous
  • 1
  • 2
  • Next >

Recent Articles

  • Insights on Voting Rights and Share Issuance from Nyxoah
  • Amedisys Delivers Strong Q2 Growth in Financial Performance
  • Quad Graphics: Q2 2025 Financial Highlights and Insights
  • Electronic Arts Reports Strong Q1 Results and Future Plans
  • Amedisys, Inc. Shows Promising Growth in Financial Outcomes
  • Celebrate National Avocado Day with Island Fin Poké Co. Offers
  • Replimune Group, Inc. Faces Class Action Amid Challenges
  • MARA Sees Stellar Growth in Second Quarter Financials
  • Scripps Expands Senior Notes Offering to Strengthen Finances
  • EPWK Holdings Faces Nasdaq Compliance Challenges Ahead
  • Vera Bradley Investors Urged to Assess Class Action Opportunities
  • Howmet Aerospace Declares Dividends for Common and Preferred Stocks
  • Kadant Inc. Reports Q2 2025 Financial Results and Insights
  • BitMart's Innovative Strategies for Localizing Crypto Services
  • Kedrion Biopharma Advances Clinical Trials for Rare Bleeding Disorder
  • American Assets Trust, Inc. Sees Growth from Q2 Financials
  • Bristow Group Set to Release Vital Q2 2025 Financial Results
  • Silvaco's Strategic Acquisition of Mixel Enhances Its IP Portfolio
  • Community Healthcare Trust Reports Q2 Financial Results
  • Neogen Corporation Faces Class Action: Investors Seek Justice
  • Counterpart Health Enhances Operational Strategy with New VP
  • HMI and PSI Unite to Innovate in Mining and Infrastructure
  • SI-BONE to Share Insights at Canaccord Genuity Annual Growth Event
  • Nyxoah Plans Financial Results Release for Q2 2025 Soon
  • STARZ Announces Earnings Report and Investor Call for 2025
  • Quad Reports Second Quarter Financial Performance for 2025
  • InterDigital and Samsung Finalize License Agreement After Arbitration
  • Silvaco Expands Its Portfolio with Mixel Acquisition in Connectivity
  • Nick Stanage Strengthens HII Board with Aerospace Expertise
  • Counterpart Health Welcomes Vicky Bruner as New VP of Operations
  • LG&E and KU Strengthen Energy Infrastructure for Future Growth
  • Home Federal Bancorp Reports Encouraging Financial Growth
  • Capital Power Boosts Dividends on Common and Preference Shares
  • Siegfried Group Enhances Service Reach with New DFW Market
  • Fold Holdings Prepares for Earnings Call with Major Updates
  • The Incredible Growth of Sterling Infrastructure Over 15 Years
  • Unitil Corporation Announces Regular Dividend for Shareholders
  • Farmers Challenge the Tech Startup Culture: A Call for Action
  • Capital Power Boosts Dividend by 6%, Engaging Stakeholders
  • Starbucks Q3 Results: Analyzing Growth Amid Challenges
  • LG&E and KU Collaborate to Meet Kentucky's Energy Demands
  • Nyxoah Set to Announce Q2 2025 Earnings Results Soon
  • Kadant's Strong Performance in Q2 2025: A Financial Overview
  • Understanding AWI's P/E Ratio: Insights and Analysis
  • Dragonfly Energy Launches Public Offering to Boost Growth
  • H&R Block Announces Fourth Quarter and Annual Results Update
  • Landstar System's Recent Earnings Show Strong Performance Trends
  • Market Insights into SolarEdge Technologies Trading Trends
  • Understanding MP Materials' Options Activity and Market Trends
  • Lululemon Athletica: Insights Into Recent Options Trends
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site